Glucose control in type 1 diabetes after pancreas transplantation: does automated delivery offer comparable results?
Zahradnická M, Nemétová L, Kahle M, et al.
Diabetes Technol Ther. Pub. online 25 Mar 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Interplay of chronic kidney disease and the effects of tirzepatide in patients with heart failure, preserved ejection fraction, and obesity: the SUMMIT trial
Packer M, Zile MR, Kramer CM, et al.
J Am Coll Cardiol. Pub. online 24 Mar 2025.
Leggi
Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial
Zhu Y, Jun M, Fletcher RA, et al.
Diabetes Obes Metab. Pub. online 27 Mar 2025.
Leggi
Cardiometabolic effects of tirzepatide in type 2 diabetes: individual variation and relationship to cardiovascular outcomes
Aminorroaya A, Oikonomou EK, Biswas D, et al.
JACC. Pub. online 30 Mar 2025.
Leggi
Dynamic relationships among continuous glucose metrics and momentary cognitive performance in diverse adults with type 1 diabetes
Hoogendoorn CJ, Hernandez R, Schneider S, et al.
Diabetes Care. 2025:dc242431.
Leggi
Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials
Lee MMY, Sattar N, Pop-Busui R, et al.
Diabetes Care. 2025:dc250241.
Leggi
Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes
McGuire DK, Marx N, Mulvagh SL, et al.
N Engl J Med. Pub. online 29 Mar 2025.
Leggi
Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening
Bonifacio E, Ziegler AG
Diabetes Obes Metab. Pub. online 25 Mar 2025.
Leggi
Dapagliflozin in patients undergoing transcatheter aortic-valve implantation
Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, et al.
N Engl J Med. Pub. online 29 Mar 2025.
Leggi
Semaglutide and nonarteritic anterior ischemic optic neuropathy risk among patients with diabetes
Hsu AY, Kuo HT, Wang YH, et al.
JAMA Ophthalmol. Pub. online 27 Mar 2025.
Leggi